In summary, innovative physio-metabolic imaging methods provide valuable functional and metabolic insights into tumor pathophysiology and enable a reliable preoperative classification of the IDH gene status of gliomas even with a smaller amount of data. The gene discussed is IDH1; the disease is glioma.